Rivastigmine Tartrate

Product NDC
0781-2615
11-digit product format
007812615
Labeler code
0781
Product ID
0781-2615_3375f1a6-a261-4c5c-81ee-674a11cefaf8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
rivastigmine tartrate
Dosage form
CAPSULE
Route
ORAL
Labeler
Sandoz Inc
Application
NDA020823
Marketing category
NDA AUTHORIZED GENERIC
Marketing start
2000-04-30
Marketing end
0000-00-00
Substance
RIVASTIGMINE TARTRATE
Active strength
3 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC exclude flag
E
Listing certified through
2018-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
0781-2615-602020-10-07C16284748780-19d75b9d0-7c3c-f424-e053-dadaa90a57ce4e775022-4b71-4716-bc9b-f374edaf9edb
0781-2615-602020-01-31C16284748780-19d75b9d0-7c3c-f424-e053-dadaa90a57ce4e775022-4b71-4716-bc9b-f374edaf9edb

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0781-2615-13EA - Each0781-2615d9f46389-f318-47ac-b744-97c2c5e380a212012-07-24
0781-2615-60EA - Each0781-2615f90d81f0-937f-441c-9db5-2a22f935458812012-07-24